Woodline Partners LP Amgen Inc Transaction History

Woodline Partners LP

$11 Billion
Q3 2024

A detailed history of Woodline Partners LP transactions in Amgen Inc stock. As of the latest transaction made, Woodline Partners LP holds 307,950 shares of AMGN stock, worth $91.1 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares

307,950

Previous 292,133 5.41%

Holding current value

$91.1 Million

Previous $91.3 Million 8.71%

% of portfolio

0.9%

Previous 0.92%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $4.89 Million - $5.34 Million	15,817 Added 5.41%	307,950 $99.2 Million
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $36.8 Million - $44.7 Million	139,980 Added 92.0%	292,133 $91.3 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $1.65 Million - $2 Million	6,153 Added 4.21%	152,153 $43.3 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $16.9 Million - $19 Million	66,000 Added 82.5%	146,000 $42.1 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $54.2 Million - $67.3 Million	-247,937 Reduced 75.61%	80,000 $21.5 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $53.6 Million - $63.4 Million	250,050 Added 321.04%	327,937 $72.8 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $482,513 - $588,102	2,137 Added 2.82%	77,887 $18.8 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $17.3 Million - $22 Million	75,750 New	75,750 $19.9 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $38.1 Million - $42.4 Million	-165,187 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $16.5 Million - $18.2 Million	75,083 Added 83.33%	165,187 $39.9 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $866,520 - $991,653	-4,357 Reduced 4.61%	90,104 $20.3 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $11,250 - $13,181	53 Added 0.06%	94,461 $20.1 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $2.35 Million - $2.6 Million	10,047 Added 11.91%	94,408 $23 Million
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $92.3 Million - $108 Million	-416,159 Reduced 83.15%	84,361 $21 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $108 Million - $129 Million	500,520 New	500,520 $115 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $22.6 Million - $30 Million	-124,090 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $23.5 Million - $30.2 Million	124,090 New	124,090 $29.9 Million

Others Institutions Holding AMGN

# of Institutions

3,113

Shares Held

410M

Call Options Held

Put Options Held

6.15M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Account

Woodline Partners LP Amgen Inc Transaction History